Gene PPM1D

Source: Baylor College of Medicine Summary: In this study, researchers combined clinical and laboratory studies to show that a gene called PPM1D, whose function in blood production was unknown, can confer blood cells exposed to the chemotherapy agent cisplatin a survival advantage that might favor the development of leukemia yearsRead More →

Myeloid leukemia

Source: McMaster University Summary: Researchers have provided evidence of new cancerous cells they have termed cancer regenerating cells, which are responsible for the return of acute myeloid leukemia after remission. Current therapy is effective at inducing remission in adult patients with acute myeloid leukemia, but most patients later succumb after a relapse.Read More →

DNA damage

Source: Lancaster University Summary: Researchers have now discovered how skin cells alert the immune system when their DNA is damaged in the absence of infection. They found that DNA damage can lead to an immune response similar to that observed during viral infection. Our immune system is working every day to protect us from bacteria,Read More →

Blood cancer

Source: Stanford University Medical Center Summary: According to a multicenter study, a blood test can predict which patients with a type of cancer called diffuse large B cell lymphoma are likely to respond positively to initial therapy and which are likely to need more aggressive treatment. Diffuse large B–cell lymphoma, a blood cancer,Read More →

Lymphocyte type

Source: Duke University Medical Center Summary: Researchers have tracked the missing T-cells in glioblastoma patients. The findings open a new area of exploration for adjunct cancer drugs that could free trapped T-cells from the bone marrow and improve existing immunotherapies. Glioblastoma brain tumors can have an unusual effect on the body’s immune system,Read More →

Cancer treatment

Source: Garvan Institute for Medical Research Summary: According to new findings, a naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer. Despite advances in immunotherapy for lung cancer, most patients are still treated with chemotherapy based on a drug called cisplatin. However, less than aRead More →

Blood test for prostate cancer

Source: Lawson Health Research Institute Summary: An international collaborative study is one of the first to demonstrate that a blood test can predict how patients with advanced prostate cancer will respond to specific treatments, leading to improved survival.  The study used a liquid biopsy test developed by molecular diagnostics company Epic Sciences that examines circulatingRead More →

Flu Virus Modified to treat pancreatic cancer

Source: Queen Mary, University of London Summary: According to an early study, a modified flu virus has now been used in experiments to successfully inhibit the growth of pancreatic cancer. Every year around 9,800 people in the UK are diagnosed with pancreatic cancer. The disease is particularly aggressive and has the lowest survivalRead More →

Page 1 of 212